Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 SI | General | $20.54 | 228.75K | $429.75M | -12.68 | ― | Strong Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SI | Shoulder Innovations, Inc. | 20.54 | 9.49 | 85.88% |
Analyst Ryan Zimmerman of BTIG maintained a Buy rating on Shoulder Innovations, Inc., retaining the price target of $27.00. Ryan Zimmerman’s rating is based on several factors, including Shoulder Innovations’
Reports Q3 revenue $16.2M, consensus $15.46M. “Our Q3 results reflect the consistency of our commercial model, as we added new surgeons ahead of plan, grew volume within our existing customer
2026 revenue consensus $68.42M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on
Two of the private market’s most closely watched unicorns made headlines this week, as Shield AI unveiled plans for a multibillion-dollar acquisition and Kalshi boosted its valuation to $40B following
BTIG raised the firm’s price target on Shoulder Innovations (SI) to $27 from $26 and keeps a Buy rating on the shares as part of a broader research note previewing
Shoulder Innovations, Inc. ( ($SI) ) has issued an update. Shoulder Innovations, Inc., a commercial-stage medical technology firm specializing in shoulder arthroplasty, develops advanced implant systems and an integrated ecosystem
Meeting to be held on September 22 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot
Shoulder Innovations (SI) announced it has received U.S. FDA 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity. Alongside the clearance, the company
Shoulder Innovations (SI) has entered into an exclusive collaboration with ALM Ortho, which deals in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of
Shoulder Innovations (SI) announced that it has entered into a settlement agreement with Catalyst OrthoScience to resolve all outstanding patent litigation between the two companies. The terms of the settlement
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| SI | Mar 16, 2027TBA | $429.75M | $-0.45 | $19.34M | -0.05 | -12.68 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
